On the other hand, the increasing evidence of elevated postprandial GLP-1 levels observed in obese people after Roux-Y gastric bypass surgery, together with amelioration of hyperglycemia and insulin resistance, strongly suggests benefits of recruiting endogenous GLP-1 as an alternative treatment [49]. The gene discussed is GLP1R; the disease is Hyperglycemia.